Primary Tumor Resection for M1a Stage Lung Cancer With Occult Pleural Dissemination Discovered During Surgery: a Prospective, Single-arm, Multi-center, Phase Ⅱ Trial

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1023. This study aims to explore the safety and efficacy of primary lesion resection in the treatment of M1a stage lung cancer with pleural dissemination found during surgery, and to more accurately evaluate whether primary lesion resection can improve the OS and quality of life of the corresponding patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Volunteer to participate in clinical research, willing to follow and able to complete all trial procedures;

• Aged 18-80 years (including critical values) when signing the informed consent form;

• ECOG score 0 or 1;

• No previous lung cancer surgery;

• Intraoperative or postoperative pathological confirmation of M1a stage lung cancer;

• Occult pleural metastasis found during surgery;

• Preoperative lymph node staging is cN0;

• First-time treatment and no radiotherapy or chemotherapy.

Locations
Other Locations
China
Fudan University Cancer Center
RECRUITING
Shanghai
Contact Information
Primary
Fangqiu Fu, MD
fufangqiu12@163.com
021-64175590
Time Frame
Start Date: 2024-04-01
Estimated Completion Date: 2026-06
Participants
Target number of participants: 66
Related Therapeutic Areas
Sponsors
Leads: Fudan University

This content was sourced from clinicaltrials.gov